{"slideshow_credits": null, "snippet": "A reader says the company, which may reincorporate in Britain, should be grateful for all that it gets for its U.S. taxes.", "abstract": null, "section_name": "Opinion", "print_page": "", "document_type": "article", "byline": [], "web_url": "http://www.nytimes.com/2014/05/07/opinion/pfizers-tax-driven-plan.html", "lead_paragraph": "A reader says the company, which may reincorporate in Britain, should be grateful for all that it gets for its U.S. taxes.", "headline": {"main": "Pfizer\u2019s Tax-Driven Plan", "print_headline": "Pfizer\u2019s Tax-Driven Plan", "content_kicker": "Letter", "kicker": "Letter"}, "_id": "5369623738f0d86f20fb8c78", "word_count": "172", "multimedia": [], "pub_date": "2014-05-07T00:00:00Z", "source": "The New York Times", "news_desk": "Letters", "keywords": [{"value": "Great Britain", "name": "glocations", "is_major": "N", "rank": "4"}, {"value": "Pfizer Inc", "name": "organizations", "is_major": "N", "rank": "2"}, {"value": "United States", "name": "glocations", "is_major": "N", "rank": "5"}, {"value": "Corporate Taxes", "name": "subject", "is_major": "N", "rank": "1"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "3"}], "blog": [], "subsection_name": null, "type_of_material": "Letter"}